These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 6457989)

  • 41. Study of artificial flavouring substances for mutagenicity in the Salmonella/microsome, Basc and micronucleus tests.
    Wild D; King MT; Gocke E; Eckhardt K
    Food Chem Toxicol; 1983 Dec; 21(6):707-19. PubMed ID: 6420251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary studies on the ability of Drosophila microsomal preparations to activate mutagens and carcinogens.
    Baars AJ; Blijleven WG; Mohn GR; Natarajan AT; Breimer DD
    Mutat Res; 1980 Sep; 72(2):257-64. PubMed ID: 6777691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)- 1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test.
    Skeggs HR; Berglund RM; VandenHeuvel WJ; Mrozik H; Wislocki PG; Wolf FJ
    Mutat Res; 1984 Apr; 136(1):1-8. PubMed ID: 6371510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotoxicity studies with mineral oils; effects of oils on the microbial mutagenicity of precursor mutagens and genotoxic metabolites.
    Watson WP; Brooks TM; Gonzalez LP; Wright AS
    Mutat Res; 1985 Apr; 149(2):159-70. PubMed ID: 3920514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.
    Ashby J; Vogel EW; Tinwell H; Callander RD; Shuker DE
    Mutat Res; 1993 Mar; 286(1):101-9. PubMed ID: 7678906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mutagenicity of captan and related fungicides.
    Bridges BA
    Mutat Res; 1975; 32(1):3-34. PubMed ID: 124818
    [No Abstract]   [Full Text] [Related]  

  • 51. Microbial mutagenicity of selected hydrazines.
    Rogan EG; Walker BA; Gingell R; Nagel DL; Toth B
    Mutat Res; 1982 Dec; 102(4):413-24. PubMed ID: 6757742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International Commission for Protection against Environmental Mutagens and Carcinogens. Committee 2 Final Report. Mutagenesis testing as an approach to carcinogenesis.
    Mutat Res; 1982 Jul; 99(1):73-91. PubMed ID: 6214712
    [No Abstract]   [Full Text] [Related]  

  • 53. Present and future uses of mutagenicity tests for assessment of the safety of food additives.
    Green S
    J Environ Pathol Toxicol; 1977; 1(2):49-54. PubMed ID: 121932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutagenicity of 43 structurally related heterocyclic compounds and its relationship to their carcinogenicity.
    Glatt HR; Schwind H; Zajdela F; Croisy A; Jacquignon PC; Oesch F
    Mutat Res; 1979 Apr; 66(4):307-28. PubMed ID: 379627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mutagenicity of azathioprine in mice, Drosophila melanogaster and Neurospora crassa.
    Clark JM
    Mutat Res; 1975 Apr; 28(1):87-99. PubMed ID: 124817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenicity studies with x-ray-contrast media, analgesics, antipyretics, antirheumatics and some other pharmaceutical drugs in bacterial, Drosophila and mammalian test systems.
    King MT; Beikirch H; Eckhardt K; Gocke E; Wild D
    Mutat Res; 1979 Jan; 66(1):33-43. PubMed ID: 106272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.